Track the 안트로젠 stock price and the full insider trade history of the company, a listed issuer based in South Korea. Shares are listed on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 안트로젠 has recorded 28 insider filings. The latest transaction was reported on 10 July 2026 (Purchase). Among the most active insiders: 이성구. The full history is accessible without an account.
28
Insider Decl.
n/a
Thresholds
n/a
11 ops.
Buy Volume
n/a
2 ops.
Sell Volume
5Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
안트로젠 is a healthcare and pharmaceutical company listed on the XKRX market. It specializes in the development of biological treatments and innovative therapies.